SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1–Nrf2
Anne‐Valérie Burgener(University Hospital of Basel), Glenn R. Bantug(University of Cambridge), B. Meyer(University Hospital of Basel), Rebecca Higgins(University Hospital of Basel), Adhideb Ghosh(Board of the Swiss Federal Institutes of Technology), Olivier Bignucolo(University of Lausanne), H. Eric(Van Andel Institute), Jordan Loeliger(University Hospital of Basel), Gunhild Unterstab(University Hospital of Basel), Marco Geigges(Board of the Swiss Federal Institutes of Technology), Rebekah Steiner(University Hospital of Basel), Michel Enamorado(National Institutes of Health), Robert Ivánek(University Hospital of Basel), Danielle Hunziker(University Hospital of Basel), Alexander Schmidt(University of Basel), Bojana Müller-Durovic(University Hospital of Basel), Jasmin Grählert(University Hospital of Basel), Raja Epple(University Hospital of Basel), Sarah Dimeloe(University of Birmingham), Jonas Lötscher(University Hospital of Basel), Ursula Sauder(University of Basel), Monika Ebnöther(St. Claraspital), Bettina Burger(University Hospital of Basel), Ingmar Heijnen(University Hospital of Basel), Sarai Martínez-Cano(Spanish National Centre for Cardiovascular Research), Nathan Cantoni(Kantonsspital Aarau), Rolf Brücker(Hirslanden Klinik St. Anna), Christian R. Kahlert(University of St.Gallen), David Sancho(Spanish National Centre for Cardiovascular Research), Russell G. Jones(Van Andel Institute), Alexander A. Navarini(University Hospital of Basel), Mike Recher(University Hospital of Basel), Christoph Hess(University of Cambridge)
Cited by 55Open Access